Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 347
Filter
1.
Lipids Health Dis ; 23(1): 216, 2024 Jul 13.
Article in English | MEDLINE | ID: mdl-39003477

ABSTRACT

BACKGROUND: The regulation of the circadian clock genes, which coordinate the activity of the immune system, is disturbed in inflammatory bowel disease (IBD). Emerging evidence suggests that butyrate, a short-chain fatty acid produced by the gut microbiota is involved in the regulation of inflammatory responses as well as circadian-clock genes. This study was conducted to investigate the effects of sodium-butyrate supplementation on the expression of circadian-clock genes, inflammation, sleep and life quality in active ulcerative colitis (UC) patients. METHODS: In the current randomized placebo-controlled trial, 36 active UC patients were randomly divided to receive sodium-butyrate (600 mg/kg) or placebo for 12-weeks. In this study the expression of circadian clock genes (CRY1, CRY2, PER1, PER2, BMAl1 and CLOCK) were assessed by real time polymerase chain reaction (qPCR) in whole blood. Gene expression changes were presented as fold changes in expression (2^-ΔΔCT) relative to the baseline. The faecal calprotectin and serum level of high-sensitivity C-reactive protein (hs-CRP) were assessed by enzyme-linked immunosorbent assay method (ELIZA). Moreover, the sleep quality and IBD quality of life (QoL) were assessed by Pittsburgh sleep quality index (PSQI) and inflammatory bowel disease questionnaire-9 (IBDQ-9) respectively before and after the intervention. RESULTS: The results showed that sodium-butyrate supplementation in comparison with placebo significantly decreased the level of calprotectin (-133.82 ± 155.62 vs. 51.58 ± 95.57, P-value < 0.001) and hs-CRP (-0.36 (-1.57, -0.05) vs. 0.48 (-0.09-4.77), P-value < 0.001) and upregulated the fold change expression of CRY1 (2.22 ± 1.59 vs. 0.63 ± 0.49, P-value < 0.001), CRY2 (2.15 ± 1.26 vs. 0.93 ± 0.80, P-value = 0.001), PER1 (1.86 ± 1.77 vs. 0.65 ± 0.48, P-value = 0.005), BMAL1 (1.85 ± 0.97 vs. 0.86 ± 0.63, P-value = 0.003). Also, sodium-butyrate caused an improvement in the sleep quality (PSQI score: -2.94 ± 3.50 vs. 1.16 ± 3.61, P-value < 0.001) and QoL (IBDQ-9: 17.00 ± 11.36 vs. -3.50 ± 6.87, P-value < 0.001). CONCLUSION: Butyrate may be an effective adjunct treatment for active UC patients by reducing biomarkers of inflammation, upregulation of circadian-clock genes and improving sleep quality and QoL.


Subject(s)
Colitis, Ulcerative , Dietary Supplements , Sleep Quality , Humans , Colitis, Ulcerative/drug therapy , Colitis, Ulcerative/genetics , Colitis, Ulcerative/metabolism , Male , Female , Adult , Double-Blind Method , Middle Aged , Inflammation/genetics , Inflammation/drug therapy , C-Reactive Protein/metabolism , C-Reactive Protein/genetics , Quality of Life , Circadian Clocks/genetics , Circadian Clocks/drug effects , Leukocyte L1 Antigen Complex/genetics , Leukocyte L1 Antigen Complex/metabolism , Gene Expression Regulation/drug effects , Butyrates , Butyric Acid
2.
Dev Neurobiol ; 84(3): 191-202, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38830726

ABSTRACT

Assessing the impact of food additives on neurodevelopmental processes extends beyond traditional acute toxicity evaluations to address subtler, long-term effects. This study investigates the impact of common food additives (tartrazine, sunset yellow, sodium benzoate, and aspartame) on neurodevelopment in zebrafish embryos, observed from 18 hours postfertilization (hpf) to 91 days postfertilization (dpf). Results show reduced 96 hpf locomotor activity after aspartame exposure, with elevated additives correlating with decreased heart rates and induced neurodegenerative phenotypes, including bent tails and abnormal pigmentation. Although locomotor activity decreases at 7 days postexposure, a gradual recovery is observed. Transcriptome analysis indicates alterations in clock genes (Cry2 and Per2) and dopamine-related genes (NURR1 and tyrosine hydroxylase) in zebrafish larvae. Dietary additive exposure during embryonic development impacts clock genes, influencing dopamine activity and resulting in neurobehavioral changes. This study underscores potential risks associated with dietary additive exposure during critical developmental stages, warranting reconsideration of consumption guidelines, especially for expectant mothers. Observed neurodevelopmental toxicity, even below recommended levels, emphasizes the importance of safeguarding neurodevelopmental health in early life. Our findings contribute to understanding the neurotoxic effects of dietary additives, emphasizing the necessity of protecting neurodevelopment during vulnerable periods. This study is the first to demonstrate a direct correlation between food additives and the dysregulation of key circadian rhythm and dopaminergic genes in zebrafish, providing new insights into the neurodevelopmental impacts of dietary additives. These findings pave the way for further research into the molecular mechanisms and potential implications for human health.


Subject(s)
Circadian Clocks , Dopamine , Zebrafish , Animals , Dopamine/metabolism , Circadian Clocks/drug effects , Circadian Clocks/genetics , Circadian Clocks/physiology , Food Additives/toxicity , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolism , Embryo, Nonmammalian/drug effects , Locomotion/drug effects , Locomotion/physiology
3.
Cell Mol Neurobiol ; 44(1): 51, 2024 Jun 22.
Article in English | MEDLINE | ID: mdl-38907776

ABSTRACT

The circadian system is a conserved time-keeping machinery that regulates a wide range of processes such as sleep/wake, feeding/fasting, and activity/rest cycles to coordinate behavior and physiology. Circadian disruption can be a contributing factor in the development of metabolic diseases, inflammatory disorders, and higher risk of cancer. Glioblastoma (GBM) is a highly aggressive grade 4 brain tumor that is resistant to conventional therapies and has a poor prognosis after diagnosis, with a median survival of only 12-15 months. GBM cells kept in culture were shown to contain a functional circadian oscillator. In seeking more efficient therapies with lower side effects, we evaluated the pharmacological modulation of the circadian clock by targeting the cytosolic kinases glycogen synthase kinase-3 (GSK-3) and casein kinase 1 ε/δ (CK1ε/δ) with specific inhibitors (CHIR99021 and PF670462, respectively), the cryptochrome protein stabilizer (KL001), or circadian disruption after Per2 knockdown expression in GBM-derived cells. CHIR99021-treated cells had a significant effect on cell viability, clock protein expression, migration, and cell cycle distribution. Moreover, cultures exhibited higher levels of reactive oxygen species and alterations in lipid droplet content after GSK-3 inhibition compared to control cells. The combined treatment of CHIR99021 with temozolomide was found to improve the effect on cell viability compared to temozolomide therapy alone. Per2 disruption affected both GBM migration and cell cycle progression. Overall, our results suggest that pharmacological modulation or molecular clock disruption severely affects GBM cell biology.


Subject(s)
Brain Neoplasms , Glioblastoma , Glioblastoma/pathology , Glioblastoma/metabolism , Glioblastoma/drug therapy , Humans , Cell Line, Tumor , Brain Neoplasms/pathology , Brain Neoplasms/metabolism , Brain Neoplasms/drug therapy , Pyridines/pharmacology , Cell Survival/drug effects , Cytosol/metabolism , Cytosol/drug effects , Glycogen Synthase Kinase 3/metabolism , Pyrimidines/pharmacology , Cell Movement/drug effects , Circadian Clocks/drug effects , Circadian Clocks/physiology , CLOCK Proteins/metabolism , CLOCK Proteins/genetics , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Reactive Oxygen Species/metabolism
4.
Nutrients ; 16(10)2024 May 15.
Article in English | MEDLINE | ID: mdl-38794729

ABSTRACT

Polymethoxyflavonoids, such as nobiletin (abundant in Citrus depressa), have been reported to have antioxidant, anti-inflammatory, anticancer, and anti-dementia effects, and are also a circadian clock modulator through retinoic acid receptor-related orphan receptor (ROR) α/γ. However, the optimal timing of nobiletin intake has not yet been determined. Here, we explored the time-dependent treatment effects of nobiletin and a possible novel mechanistic idea for nobiletin-induced circadian clock regulation in mice. In vivo imaging showed that the PER2::LUC rhythm in the peripheral organs was altered in accordance with the timing of nobiletin administration (100 mg/kg). Administration at ZT4 (middle of the light period) caused an advance in the peripheral clock, whereas administration at ZT16 (middle of the dark period) caused an increase in amplitude. In addition, the intraperitoneal injection of nobiletin significantly and potently stimulated corticosterone and adrenaline secretion and caused an increase in Per1 expression in the peripheral tissues. Nobiletin inhibited phosphodiesterase (PDE) 4A1A, 4B1, and 10A2. Nobiletin or rolipram (PDE4 inhibitor) injection, but not SR1078 (RORα/γ agonist), caused acute Per1 expression in the peripheral tissues. Thus, the present study demonstrated a novel function of nobiletin and the regulation of the peripheral circadian clock.


Subject(s)
Circadian Clocks , Corticosterone , Flavones , Animals , Flavones/pharmacology , Circadian Clocks/drug effects , Mice , Male , Corticosterone/blood , Period Circadian Proteins/metabolism , Period Circadian Proteins/genetics , Epinephrine , Mice, Inbred C57BL , Nuclear Receptor Subfamily 1, Group F, Member 1/metabolism , Circadian Rhythm/drug effects , Circadian Rhythm/physiology
5.
Horm Behav ; 163: 105562, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38810363

ABSTRACT

The embryonic environment is critical in shaping developmental trajectories and consequently post-natal phenotypes. Exposure to elevated stress hormones during this developmental stage is known to alter a variety of post-natal phenotypic traits, and it has been suggested that pre-natal stress can have long term effects on the circadian rhythm of glucocorticoid hormone production. Despite the importance of the circadian system, the potential impact of developmental glucocorticoid exposure on circadian clock genes, has not yet been fully explored. Here, we showed that pre-natal exposure to corticosterone (CORT, a key glucocorticoid) resulted in a significant upregulation of two key hypothalamic circadian clock genes during the embryonic period in the Japanese quail (Coturnix japonica). Altered expression was still present 10 days into post-natal life for both genes, but then disappeared by post-natal day 28. At post-natal day 28, however, diel rhythms of eating and resting were influenced by exposure to pre-natal CORT. Males exposed to pre-natal CORT featured an earlier acrophase, alongside spending a higher proportion of time feeding. Females exposed to pre-natal CORT featured a less pronounced shift in acrophase and spent less time eating. Both males and females exposed to pre-natal CORT spent less time inactive during the day. Pre-natal CORT males appeared to feature a delay in peak activity levels. Our novel data suggest that these circadian clock genes and aspects of diurnal behaviours are highly susceptible to glucocorticoid disruption during embryonic development, and these effects are persistent across developmental stages, at least into early post-natal life.


Subject(s)
Circadian Clocks , Corticosterone , Coturnix , Glucocorticoids , Animals , Coturnix/genetics , Female , Male , Circadian Clocks/drug effects , Circadian Clocks/genetics , Gene Expression Regulation, Developmental/drug effects , Circadian Rhythm/drug effects , Behavior, Animal/drug effects , Pregnancy , Hypothalamus/drug effects , Hypothalamus/metabolism
6.
JCI Insight ; 9(9)2024 May 08.
Article in English | MEDLINE | ID: mdl-38716727

ABSTRACT

Pancreatic ductal adenocarcinoma (PDA) is a lethal cancer characterized by a poor outcome and an increasing incidence. A significant majority (>80%) of newly diagnosed cases are deemed unresectable, leaving chemotherapy as the sole viable option, though with only moderate success. This necessitates the identification of improved therapeutic options for PDA. We hypothesized that there are temporal variations in cancer-relevant processes within PDA tumors, offering insights into the optimal timing of drug administration - a concept termed chronotherapy. In this study, we explored the presence of the circadian transcriptome in PDA using patient-derived organoids and validated these findings by comparing PDA data from The Cancer Genome Atlas with noncancerous healthy pancreas data from GTEx. Several PDA-associated pathways (cell cycle, stress response, Rho GTPase signaling) and cancer driver hub genes (EGFR and JUN) exhibited a cancer-specific rhythmic pattern intricately linked to the circadian clock. Through the integration of multiple functional measurements for rhythmic cancer driver genes, we identified top chronotherapy targets and validated key findings in molecularly divergent pancreatic cancer cell lines. Testing the chemotherapeutic efficacy of clinically relevant drugs further revealed temporal variations that correlated with drug-target cycling. Collectively, our study unravels the PDA circadian transcriptome and highlights a potential approach for optimizing chrono-chemotherapeutic efficacy.


Subject(s)
Carcinoma, Pancreatic Ductal , Pancreatic Neoplasms , Transcriptome , Humans , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/drug therapy , Pancreatic Neoplasms/pathology , Carcinoma, Pancreatic Ductal/genetics , Carcinoma, Pancreatic Ductal/drug therapy , Carcinoma, Pancreatic Ductal/pathology , Cell Line, Tumor , Gene Expression Regulation, Neoplastic/drug effects , Circadian Rhythm/genetics , Organoids/drug effects , Circadian Clocks/genetics , Circadian Clocks/drug effects , Antineoplastic Agents/therapeutic use , Antineoplastic Agents/pharmacology , Adenocarcinoma/genetics , Adenocarcinoma/drug therapy , Adenocarcinoma/pathology , Chronotherapy/methods
7.
Adv Nutr ; 15(6): 100232, 2024 06.
Article in English | MEDLINE | ID: mdl-38648895

ABSTRACT

Circadian clocks regulate metabolic homeostasis. Disruption to our circadian clocks, by lifestyle behaviors such as timing of eating and sleeping, has been linked to increased rates of metabolic disorders. There is now considerable evidence that selected dietary (poly)phenols, including flavonoids, phenolic acids and tannins, may modulate metabolic and circadian processes. This review evaluates the effects of (poly)phenols on circadian clock genes and linked metabolic homeostasis in vitro, and potential mechanisms of action, by critically evaluating the literature on mammalian cells. A systematic search was conducted to ensure full coverage of the literature and identified 43 relevant studies addressing the effects of (poly)phenols on cellular circadian processes. Nobiletin and tangeretin, found in citrus, (-)-epigallocatechin-3-gallate from green tea, urolithin A, a gut microbial metabolite from ellagitannins in fruit, curcumin, bavachalcone, cinnamic acid, and resveratrol at low micromolar concentrations all affect circadian molecular processes in multiple types of synchronized cells. Nobiletin emerges as a putative retinoic acid-related orphan receptor (RORα/γ) agonist, leading to induction of the circadian regulator brain and muscle ARNT-like 1 (BMAL1), and increased period circadian regulator 2 (PER2) amplitude and period. These effects are clear despite substantial variations in the protocols employed, and this review suggests a methodological framework to help future study design in this emerging area of research.


Subject(s)
Circadian Clocks , Homeostasis , Polyphenols , Circadian Clocks/drug effects , Circadian Clocks/genetics , Humans , Homeostasis/drug effects , Animals , Polyphenols/pharmacology , Circadian Rhythm/drug effects , Catechin/pharmacology , Catechin/analogs & derivatives , Tannins/pharmacology , Tea , Cells, Cultured , Flavones/pharmacology , Citrus
8.
Medicine (Baltimore) ; 103(5): e36266, 2024 Feb 02.
Article in English | MEDLINE | ID: mdl-38306565

ABSTRACT

Numerous studies have demonstrated an intimate relationship between circadian rhythm disorders and the development and prevention of depression. The biological clock genes, which constitute the molecular basis of endogenous circadian rhythms, hold promising prospects for depression treatment. Based on an extensive review of recent domestic and international research, this article presents a comprehensive analysis of how traditional Chinese medicine (TCM) intervenes in depression by regulating circadian rhythms. The findings indicate that TCM exerts its antidepressant effects by targeting specific biological clock genes such as Bmal1, clock, Arntl, Per1, Per2, Per3, Nr1d1, Cry2, and Dbp, as well as regulating circadian rhythms of hormone secretion. However, most current research is still confined to basic experimental studies, lacking clinical double-blind control trials to further validate these viewpoints. Furthermore, there is insufficient research on the signal transduction pathway between biological clock genes and pathological changes in depression. Additionally, further clarification is needed regarding the specific targets of TCM on the biological clock genes.


Subject(s)
Antidepressive Agents , Circadian Clocks , Medicine, Chinese Traditional , Humans , Circadian Clocks/drug effects , Circadian Clocks/genetics , Circadian Rhythm/drug effects , Circadian Rhythm/genetics , Cryptochromes/genetics , Cryptochromes/metabolism , Period Circadian Proteins/genetics , Period Circadian Proteins/metabolism , Antidepressive Agents/pharmacology , Antidepressive Agents/therapeutic use
9.
Bioorg Med Chem Lett ; 98: 129588, 2024 Jan 15.
Article in English | MEDLINE | ID: mdl-38086467

ABSTRACT

In vitro screening of a focused library of compounds containing an electrophilic warhead identified N-chloroacetyl-bis(trifluoromethyl)aniline derivative 15 as a potent inhibitor of BMAL1-CLOCK heterodimer binding to an E-box DNA fragment. Kinetic analysis of thiol-reactivity demonstrated that iodoacetamide and structurally related 20 are significantly more reactive than or equally reactive as 15, respectively, whereas none inhibited BMAL1-CLOCK interaction with the E-box DNA fragment. These results suggest that 15 binds and reacts with a specific nucleophilic residue. This low-molecular-weight compound may serve as a useful lead for further development of BMAL1-CLOCK inhibitors.


Subject(s)
Aniline Compounds , Circadian Clocks , ARNTL Transcription Factors/antagonists & inhibitors , ARNTL Transcription Factors/metabolism , Circadian Clocks/drug effects , Circadian Clocks/genetics , Circadian Rhythm/drug effects , DNA/metabolism , Kinetics , Aniline Compounds/chemistry
10.
Biochem Biophys Res Commun ; 658: 88-96, 2023 05 28.
Article in English | MEDLINE | ID: mdl-37027909

ABSTRACT

Renewal of retinal photoreceptor outer segments is conducted through daily shedding of distal photoreceptor outer segment tips and subsequent their phagocytosis by the adjacent retinal pigment epithelium (RPE) monolayer. Dysregulation of the diurnal clearance of photoreceptor outer segment tips has been implicated in age-related retinal degeneration, but it remains to be clarified how the circadian phagocytic activity of RPE cells is modulated by senescence. In this study, we used the human RPE cell line ARPE-19 to investigate whether hydrogen peroxide (H2O2)-induced senescence in ARPE-19 cells alters the circadian rhythm of their phagocytic activity. After synchronization of the cellular circadian clock by dexamethasone treatment, the phagocytic activity of normal ARPE-19 cells exhibited significant 24-h oscillation, but this oscillation was modulated by senescence. The phagocytic activity of senescent ARPE-19 cells increased constantly throughout the 24-h period, which still exhibited blunted circadian oscillation, accompanied by an alteration in the rhythmic expression of circadian clock genes and clock-controlled phagocytosis-related genes. The expression levels of REV-ERBα, a molecular component of the circadian clock, were constitutively increased in senescent ARPE-19 cells. Furthermore, pharmacological activation of REV-ERBα by its agonist SR9009 enhanced the phagocytic activity of normal ARPE-19 cells and increased the expression of clock-controlled phagocytosis-related genes. Our present findings extend to understand the role of circadian clock in the alteration of phagocytic activity in RPE during aging. Constitutive enhancement of phagocytic activity of senescent RPE may contribute to age-related retinal degeneration.


Subject(s)
Cellular Senescence , Circadian Rhythm , Phagocytosis , Retinal Pigment Epithelium , Humans , Cell Line , Cellular Senescence/drug effects , Cellular Senescence/physiology , Circadian Clocks/drug effects , Circadian Clocks/genetics , Circadian Clocks/physiology , Circadian Rhythm/drug effects , Circadian Rhythm/genetics , Circadian Rhythm/physiology , CLOCK Proteins/genetics , Dexamethasone/pharmacology , Hydrogen Peroxide/pharmacology , Phagocytosis/drug effects , Phagocytosis/physiology , Retinal Degeneration/metabolism , Retinal Pigment Epithelium/cytology , Retinal Pigment Epithelium/drug effects , Retinal Pigment Epithelium/metabolism , Time Factors
11.
Pharm Biol ; 60(1): 689-698, 2022 Dec.
Article in English | MEDLINE | ID: mdl-35298359

ABSTRACT

CONTEXT: The mammalian circadian clock system regulates physiological function. Crude drugs, containing Polygalae Radix, and Kampo, combining multiple crude drugs, have been used to treat various diseases, but few studies have focussed on the circadian clock. OBJECTIVE: We examine effective crude drugs, which cover at least one or two of Kampo, for the shortening effects on period length of clock gene expression rhythm, and reveal the mechanism of shortening effects. MATERIALS AND METHODS: We prepared 40 crude drugs. In the in vitro experiments, we used mouse embryonic fibroblasts from PERIOD2::LUCIFERASE knock-in mice (background; C57BL/6J mice) to evaluate the effect of crude drugs on the period length of core clock gene, Per2, expression rhythm by chronic treatment (six days) with distilled water or crude drugs (100 µg/mL). In the in vivo experiments, we evaluated the free-running period length of C57BL/6J mice fed AIN-93M or AIN-93M supplemented with 1% crude drug (6 weeks) that shortened the period length of the PERIOD2::LUCIFERASE expression rhythm in the in vitro experiments. RESULTS: We found that Polygalae Radix (ED50: 24.01 µg/mL) had the most shortened PERIOD2::LUCIFERASE rhythm period length in 40 crude drugs and that the CaMKII pathway was involved in this effect. Moreover, long-term feeding with AIN-93M+Polygalae Radix slightly shortened the free-running period of the mouse locomotor activity rhythm. DISCUSSION AND CONCLUSIONS: Our results indicate that Polygalae Radix may be regarded as a new therapy for circadian rhythm disorder and that the CaMKII pathway may be regarded as a target pathway for circadian rhythm disorders.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinase Type 2/physiology , Circadian Clocks/drug effects , Plant Extracts/pharmacology , Polygala , Animals , Dose-Response Relationship, Drug , Male , Medicine, Kampo , Mice , Mice, Inbred C57BL , Motor Activity/drug effects , Plant Extracts/therapeutic use , Signal Transduction/drug effects
12.
Toxicol Appl Pharmacol ; 436: 115863, 2022 02 01.
Article in English | MEDLINE | ID: mdl-34998857

ABSTRACT

Solid tumors are commonly treated with cisplatin, which can cause off-target side effects in cancer patients. Chronotherapy is a potential strategy to reduce drug toxicity. To determine the effectiveness of timed-cisplatin treatment in mammals, we compared two conditions: clock disrupted jet-lag and control conditions. Under normal and disrupted clock conditions, triple-negative mammary carcinoma cells were injected subcutaneously into eight-week-old NOD.Cg-Prkdcscid/J female mice. Tumor volumes and body weights were measured in these mice before and after treatment with cisplatin. We observed an increase in tumor volumes in mice housed under disrupted clock compared to the normal clock conditions. After treatment with cisplatin, we observed a reduced tumor growth rate in mice treated at ZT10 compared to ZT22 and untreated cohorts under normal clock conditions. However, these changes were not seen with the jet-lag protocol. We also observed greater body weight loss in mice treated with ZT10 compared to ZT22 or untreated mice in the jet-lag protocol. Our observations suggest that the effectiveness of cisplatin in mammary carcinoma treatment is time-dependent in the presence of the circadian clock.


Subject(s)
Breast Neoplasms/drug therapy , Chronotherapy/adverse effects , Circadian Clocks/drug effects , Circadian Rhythm/drug effects , Cisplatin/adverse effects , Cisplatin/pharmacology , Mammary Neoplasms, Animal/drug therapy , Animals , Cell Line , Female , HEK293 Cells , Humans , Mice , Mice, Inbred NOD
13.
Sci Rep ; 12(1): 269, 2022 01 07.
Article in English | MEDLINE | ID: mdl-34997158

ABSTRACT

Drosophila's circadian clock can be perturbed by magnetic fields, as well as by lithium administration. Cryptochromes are critical for the circadian clock. Further, the radical pairs in cryptochrome also can explain magnetoreception in animals. Based on a simple radical pair mechanism model of the animal magnetic compass, we show that both magnetic fields and lithium can influence the spin dynamics of the naturally occurring radical pairs and hence modulate the circadian clock's rhythms. Using a simple chemical oscillator model for the circadian clock, we show that the spin dynamics influence a rate in the chemical oscillator model, which translates into a change in the circadian period. Our model can reproduce the results of two independent experiments, magnetic field and lithium effects on the circadian clock. Our model predicts that stronger magnetic fields would shorten the clock's period. We also predict that lithium influences the clock in an isotope-dependent manner. Furthermore, our model also predicts that magnetic fields and hyperfine interactions modulate oxidative stress. The findings of this work suggest that the quantum nature of radical pairs might play roles in the brain, as another piece of evidence in addition to recent results on xenon anesthesia and lithium effects on hyperactivity.


Subject(s)
Circadian Clocks/drug effects , Circadian Rhythm/drug effects , Cryptochromes/metabolism , Drosophila Proteins/metabolism , Drosophila melanogaster/drug effects , Eye Proteins/metabolism , Lithium Compounds/pharmacology , Magnetic Fields , Models, Biological , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism , Animals , Drosophila melanogaster/metabolism , Time Factors
14.
Biol Pharm Bull ; 44(11): 1577-1584, 2021.
Article in English | MEDLINE | ID: mdl-34719634

ABSTRACT

Daily rhythmic variations in biological functions affect the efficacy and/or toxicity of drugs: a large number of drugs cannot be expected to exhibit the same potency at different administration times. The "circadian clock" is an endogenous timing system that broadly regulates metabolism, physiology and behavior. In mammals, this clock governs the oscillatory expression of the majority of genes with a period length of approximately 24 h. Genetic studies have revealed that molecular components of the circadian clock regulate the expression of genes responsible for the sensitivity to drugs and their disposition. The circadian control of pharmacodynamics and pharmacokinetics enables 'chrono-pharmaceutical' applications, namely drug administration at appropriate times of day to optimize the therapeutic index (efficacy vs. toxicity). On the other hand, a variety of pathological conditions also exhibit marked day-night changes in symptom intensity. Currently, novel therapeutic approaches are facilitated by the development of chemical compound targeted to key proteins that cause circadian exacerbation of disease events. This review presents an overview of the current understanding of the role of the circadian biological clock in regulating drug efficacy and disease conditions, and also describes the importance of identifying the difference in the circadian machinery between diurnal and nocturnal animals to select the most appropriate times of day to administer drugs in humans.


Subject(s)
Circadian Clocks/drug effects , Pharmaceutical Preparations/administration & dosage , Animals , Circadian Rhythm/drug effects , Humans , Pharmacokinetics , Pharmacology
15.
Nutrients ; 13(11)2021 Nov 17.
Article in English | MEDLINE | ID: mdl-34836378

ABSTRACT

Salt, commonly known as sodium chloride, is an important ingredient that the body requires in relatively minute quantities. However, consuming too much salt can lead to high blood pressure, heart disease and even disruption of circadian rhythms. The biological process of the circadian rhythm was first studied in Drosophila melanogaster and is well understood. Their locomotor activity gradually increases before the light is switched on and off, a phenomenon called anticipation. In a previous study, we showed that a high-salt diet (HSD) impairs morning anticipation behavior in Drosophila. Here, we found that HSD did not significantly disrupt clock gene oscillation in the heads of flies, nor did it disrupt PERIOD protein oscillation in clock neurons or peripheral tissues. Remarkably, we found that HSD impairs neuronal plasticity in the axonal projections of circadian pacemaker neurons. Interestingly, we showed that increased excitability in PDF neurons mimics HSD, which causes morning anticipation impairment. Moreover, we found that HSD significantly disrupts neurotransmitter-related biological processes in the brain. Taken together, our data show that an HSD affects the multiple functions of neurons and impairs physiological behaviors.


Subject(s)
Brain/drug effects , Circadian Clocks/drug effects , Circadian Rhythm/drug effects , Neuronal Plasticity/drug effects , Neurotransmitter Agents/metabolism , Sodium Chloride, Dietary/adverse effects , Sodium/adverse effects , Animals , Behavior, Animal , Biological Phenomena , Brain/metabolism , Diet , Drosophila melanogaster , Light , Locomotion , Motor Activity , Neurons/drug effects
16.
Curr Drug Metab ; 22(13): 998-1008, 2021.
Article in English | MEDLINE | ID: mdl-34802402

ABSTRACT

BACKGROUND: Intrinsic rhythms in host and cancer cells play an imperative role in tumorigenesis and anticancer therapy. Circadian medicine in cancer is principally reliant on the control of growth and development of cancer cells or tissues by targeting the molecular clock and implementing time-of-day-based anticancer treatments for therapeutic improvements. In recent years, based on extensive high-throughput studies, we witnessed the arrival of several drugs and drug-like compounds that can modulate circadian timekeeping for therapeutic gain in cancer management. OBJECTIVE: This perspective article intends to illustrate the current trends in circadian medicine in cancer, focusing on clock-modulating pharmacological compounds and circadian regulation of anticancer drug metabolism and efficacy. Scope and Approach: Considering the critical roles of the circadian clock in metabolism, cell signaling, and apoptosis, chronopharmacology research is exceedingly enlightening for understanding cancer biology and improving anticancer therapeutics. In addition to reviewing the relevant literature, we investigated the rhythmic expression of molecular targets for many anticancer drugs frequently used to treat different cancer types. Key Findings and Conclusion: There are adequate empirical pieces of evidence supporting circadian regulation of drug metabolism, transport, and detoxification. Administration of anticancer drugs at specific dosing times can improve their effectiveness and reduce the toxic effects. Moreover, pharmacological modulators of the circadian clock could be used for targeted anticancer therapeutics such as boosting circadian rhythms in the host can markedly reduce the growth and viability of tumors. All in all, precision chronomedicine can offer multiple advantages over conventional anticancer therapy.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinogenesis , Circadian Clocks , Drug Chronotherapy , Neoplasms , Administration, Metronomic , Apoptosis/drug effects , Apoptosis/physiology , Carcinogenesis/drug effects , Carcinogenesis/metabolism , Chronopharmacokinetics , Circadian Clocks/drug effects , Circadian Clocks/physiology , Circadian Rhythm/drug effects , Circadian Rhythm/physiology , Humans , Maintenance Chemotherapy/methods , Maintenance Chemotherapy/trends , Neoplasms/drug therapy , Neoplasms/metabolism , Signal Transduction/drug effects , Signal Transduction/physiology
17.
Sci Rep ; 11(1): 21038, 2021 10 26.
Article in English | MEDLINE | ID: mdl-34702865

ABSTRACT

Circadian rhythm is an approximately 24 h endogenous biological rhythm. Chronic disruption of the circadian clock leads to an increased risk of diabetes, cardiovascular disease, and cancer. Hence, it is important to develop circadian clock modulators. Natural organisms are a good source of several medicines currently in use. Crude drugs used in Japanese traditional Kampo medicine or folk medicines are an excellent source for drug discovery. Furthermore, identifying new functions for existing drugs, known as the drug repositioning approach, is a popular and powerful tool. In this study, we screened 137 crude drug extracts to act as circadian clock modulators in human U2OS cells stably expressing the clock reporter Bmal1-dLuc, and approximately 12% of these modulated the circadian rhythm. We further examined the effects of several crude drugs in Rat-1 fibroblasts stably expressing Per2-luc, explant culture of lung from Per2::Luciferase knockin mice, and zebrafish larvae in vivo. Notably, more than half of the major ingredients of these crude drugs were reported to target AKT and its relevant signaling pathways. As expected, analysis of the major ingredients targeting AKT signaling confirmed the circadian clock-modulating effects. Furthermore, activator and inhibitor of AKT, and triple knockdown of AKT isoforms by siRNA also modulated the circadian rhythm. This study, by employing the drug repositioning approach, shows that Kampo medicines are a useful source for the identification of underlying mechanisms of circadian clock modulators and could potentially be used in the treatment of circadian clock disruption.


Subject(s)
Circadian Clocks/drug effects , Complex Mixtures , Drugs, Chinese Herbal , Medicine, Kampo , Zebrafish , Animals , Cell Line, Tumor , Circadian Clocks/genetics , Complex Mixtures/chemistry , Complex Mixtures/pharmacology , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/pharmacology , Humans , Mice , Mice, Transgenic , Rats , Zebrafish/genetics , Zebrafish/metabolism
18.
Sci Rep ; 11(1): 17997, 2021 09 09.
Article in English | MEDLINE | ID: mdl-34504274

ABSTRACT

Nucleotide excision repair (NER) and cell cycle checkpoints impact the ability of the anti-cancer drug cisplatin to inhibit cell proliferation and induce cell death. Genetic studies have shown that both NER and cell cycle progression are impacted by the circadian clock, which has emerged as a novel pharmacological target for the treatment of various disease states. In this study, cultured human cell lines were treated with combinations of cisplatin and the circadian clock modulating compounds KS15 and SR8278, which enhance circadian clock transcriptional output by inhibiting the activities of the cryptochrome and REV-ERB proteins, respectively. Treatment of cells with KS15 and SR8278 protected cells against the anti-proliferative effects of cisplatin and increased the expression of NER factor XPA and cell cycle regulators Wee1 and p21 at the mRNA and protein level. Correlated with these molecular changes, KS15 and SR8278 treatment resulted in fewer unrepaired cisplatin-DNA adducts in genomic DNA and a higher fraction of cells in the G1 phase of the cell cycle. Thus, the use of pharmacological agents targeting the circadian clock could be a novel approach to modulate the responses of normal and cancer cells to cisplatin chemotherapy regimens.


Subject(s)
Antineoplastic Agents/pharmacology , Cisplatin/pharmacology , Cryptochromes/antagonists & inhibitors , DNA Adducts/drug effects , DNA Adducts/pharmacology , DNA Repair/drug effects , G1 Phase Cell Cycle Checkpoints/drug effects , Nuclear Receptor Subfamily 1, Group D, Member 1/antagonists & inhibitors , A549 Cells , Cell Cycle Proteins/metabolism , Cell Proliferation/drug effects , Cell Survival/drug effects , Circadian Clocks/drug effects , Drug Resistance, Neoplasm/drug effects , HaCaT Cells , Humans , Isoquinolines/pharmacology , Protein-Tyrosine Kinases/metabolism , Signal Transduction/drug effects , Thiophenes/pharmacology , Xeroderma Pigmentosum Group A Protein/metabolism
19.
FASEB J ; 35(9): e21803, 2021 09.
Article in English | MEDLINE | ID: mdl-34365685

ABSTRACT

Melatonin pleiotropically regulates physiological events and has a putative regulatory role in the circadian clock desynchrony-mediated Non-alcoholic fatty liver disease (NAFLD). In this study, we investigated perturbations in the hepatic circadian clock gene, and Nrf2-HO-1 oscillations in conditions of high-fat high fructose (HFHF) diet and/or jet lag (JL)-mediated NAFLD. Melatonin treatment (100 µM) to HepG2 cells led to an improvement in oscillatory pattern of clock genes (Clock, Bmal1, and Per) in oleic acid (OA)-induced circadian desynchrony, while Cry, Nrf2, and HO-1 remain oblivious of melatonin treatment that was also validated by circwave analysis. C57BL/6J mice subjected to HFHF and/or JL, and treated with melatonin showed an improvement in the profile of lipid regulatory genes (CPT-1, PPARa, and SREBP-1c), liver function (AST and ALT) and histomorphology of fatty liver. A detailed scrutiny revealed that hepatic mRNA and protein profiles of Bmal1 (at ZT6) and Clock (at ZT12) underwent corrective changes in oscillations, but moderate corrections were recorded in other components of clock genes (Per1, Per2, and Cry2). Melatonin induced changes in oscillations of anti-oxidant genes (Nrf2, HO-1, and Keap1) subtly contributed in the overall improvement in NAFLD recorded herein. Taken together, melatonin induced reprograming of hepatic core clock and Nrf2-HO-1 genes leads to an improvement in HFHF/JL-induced NAFLD.


Subject(s)
Circadian Rhythm/drug effects , Heme Oxygenase-1/metabolism , Liver/drug effects , Liver/metabolism , Melatonin/pharmacology , NF-E2-Related Factor 2/metabolism , Non-alcoholic Fatty Liver Disease/metabolism , Animals , Circadian Clocks/drug effects , Hep G2 Cells , Humans , Male , Mice , Mice, Inbred C57BL , Period Circadian Proteins/metabolism , Sterol Regulatory Element Binding Protein 1/metabolism
20.
Sci Rep ; 11(1): 16152, 2021 08 09.
Article in English | MEDLINE | ID: mdl-34373551

ABSTRACT

Chemical communication via pheromones is an integral component in insect behavior, particularly for mate searching and reproduction. Aggregation pheromones, that attract conspecifics of both sexes, are particularly common and have been identified for hundreds of species. These pheromones are among the most ecologically selective pest suppression agents. In this study, we identified an activating effect of the aggregation pheromone of the red flour beetle, Tribolium castaneum (Herbst) (Coleoptera: Tenibroidae) on a highly conserved circadian clock gene (Tctimeless). Tribolium castaneum is one of the most damaging cosmopolitan pest of flour and other stored food products. Its male produced aggregation pheromone, 4,8-dimethyldecanal (DMD), attracts both conspecific males and females and is used for pest management via monitoring and mating disruption. The Tctimeless gene is an essential component for daily expression patterns of the circadian clock and plays vital roles in eclosion, egg production, and embryonic development. In this study, we demonstrate that constant exposure to the species-specific aggregation pheromone led to Tctimeless up-regulation and a different pattern of rhythmic locomotive behavior. We propose that changing the well-adapted "alarm clock", using DMD is liable to reduce fitness and can be highly useful for pest management.


Subject(s)
Circadian Clocks/genetics , Genes, Insect , Tribolium/genetics , Tribolium/physiology , Aldehydes/administration & dosage , Aldehydes/metabolism , Animals , Circadian Clocks/drug effects , Circadian Clocks/physiology , Female , Gene Expression Profiling , Genes, Insect/drug effects , Insect Control , Insect Proteins/genetics , Insect Proteins/physiology , Male , Period Circadian Proteins/genetics , Period Circadian Proteins/physiology , Pheromones/administration & dosage , Pheromones/physiology , Reproduction/drug effects , Reproduction/genetics , Reproduction/physiology , Social Behavior , Tribolium/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...